Literature DB >> 14637138

A new human peptide deformylase inhibitable by actinonin.

Mona D Lee1, Christophe Antczak, Yueming Li, Francis M Sirotnak, William G Bornmann, David A Scheinberg.   

Abstract

Peptide deformylases (PDFs) have been investigated as potential specific targets for antibiotics, but the possible existence of a functional human PDF (HsPDF) presents a potential hurdle to the design of specific drugs. We have expression cloned a HsPDF that has deformylase activity, although it is a slower and catalytically less active enzyme than bacterial or plant PDFs. A cobalt-substituted form of HsPDF (but not nickel or zinc) is active, and the enzyme appears to be active at a pH between 6.0 and 7.2, a temperature range of 25-50 degrees C, and in a low KCl ionic strength buffer. Actinonin inhibits HsPDF activity with an IC50 of 43 nM and kills Daudi and HL60 human cancer cell lines with an LC50 of 5.3 and 8.8 microM, respectively. The inhibition of HsPDF may provide an explanation for the mechanism by which actinonin is cytotoxic against various human tumor cell lines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14637138     DOI: 10.1016/j.bbrc.2003.10.123

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  High-throughput identification of inhibitors of human mitochondrial peptide deformylase.

Authors:  Christophe Antczak; David Shum; Sindy Escobar; Bhramdeo Bassit; Earl Kim; Venkatraman E Seshan; Nian Wu; Guangli Yang; Ouathek Ouerfelli; Yue-Ming Li; David A Scheinberg; Hakim Djaballah
Journal:  J Biomol Screen       Date:  2007-04-13

2.  Structural basis for the inhibition of M1 family aminopeptidases by the natural product actinonin: Crystal structure in complex with E. coli aminopeptidase N.

Authors:  Roopa Jones Ganji; Ravikumar Reddi; Rajesh Gumpena; Anil Kumar Marapaka; Tarun Arya; Priyanka Sankoju; Supriya Bhukya; Anthony Addlagatta
Journal:  Protein Sci       Date:  2015-04-08       Impact factor: 6.725

3.  Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.

Authors:  Christophe Antczak; David Shum; Bhramdeo Bassit; Mark G Frattini; Yueming Li; Elisa de Stanchina; David A Scheinberg; Hakim Djaballah
Journal:  Bioorg Med Chem Lett       Date:  2011-06-12       Impact factor: 2.823

4.  Insights from ligand and structure based methods in virtual screening of selective Ni-peptide deformylase inhibitors.

Authors:  Ravi Shekar Ananthula; Muttineni Ravikumar; S K Mahmood; M N S Pavan Kumar
Journal:  J Mol Model       Date:  2011-05-12       Impact factor: 1.810

5.  15th European Congress of Clinical Microbiology and Infectious Diseases, Copenhagen, Denmark, 2-5 April 2005. Abstracts.

Authors: 
Journal:  Clin Microbiol Infect       Date:  2005-04       Impact factor: 8.067

6.  Peptide deformylase is a potential target for anti-Helicobacter pylori drugs: reverse docking, enzymatic assay, and X-ray crystallography validation.

Authors:  Jianhua Cai; Cong Han; Tiancen Hu; Jian Zhang; Dalei Wu; Fangdao Wang; Yunqing Liu; Jianping Ding; Kaixian Chen; Jianmin Yue; Xu Shen; Hualiang Jiang
Journal:  Protein Sci       Date:  2006-08-01       Impact factor: 6.725

7.  Peptide deformylase inhibitors as potent antimycobacterial agents.

Authors:  Jeanette W P Teo; Pamela Thayalan; David Beer; Amelia S L Yap; Mahesh Nanjundappa; Xinyi Ngew; Jeyaraj Duraiswamy; Sarah Liung; Veronique Dartois; Mark Schreiber; Samiul Hasan; Michael Cynamon; Neil S Ryder; Xia Yang; Beat Weidmann; Kathryn Bracken; Thomas Dick; Kakoli Mukherjee
Journal:  Antimicrob Agents Chemother       Date:  2006-09-11       Impact factor: 5.191

8.  Structure and activity of human mitochondrial peptide deformylase, a novel cancer target.

Authors:  Sindy Escobar-Alvarez; Yehuda Goldgur; Guangli Yang; Ouathek Ouerfelli; Yueming Li; David A Scheinberg
Journal:  J Mol Biol       Date:  2009-02-21       Impact factor: 5.469

9.  Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.

Authors:  Mona D Lee; Yuhong She; Michael J Soskis; Christopher P Borella; Jeffrey R Gardner; Paula A Hayes; Benzon M Dy; Mark L Heaney; Mark R Philips; William G Bornmann; Francis M Sirotnak; David A Scheinberg
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  Solvent-assisted slow conversion of a dithiazole derivative produces a competitive inhibitor of peptide deformylase.

Authors:  Alexander K Berg; Qingfeng Yu; Steven Y Qian; Manas K Haldar; D K Srivastava
Journal:  Biochim Biophys Acta       Date:  2009-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.